Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: Feb 11, 2022
Date Accepted: Feb 11, 2022

The final, peer-reviewed published version of this preprint can be found here:

Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”

Tagwerker C, Carias-Marines MJ, Smith DJ

Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”

JMIRx Med 2022;3(2):e37242

DOI: 10.2196/37242

PMCID: 10414351

Authors' Responses to Peer Review Reports for MS#32902

  • Christian Tagwerker; 
  • Mary Jane Carias-Marines; 
  • David J. Smith

ABSTRACT

This is the authors' responses to peer review reports related to MS# 32902


 Citation

Please cite as:

Tagwerker C, Carias-Marines MJ, Smith DJ

Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”

JMIRx Med 2022;3(2):e37242

DOI: 10.2196/37242

PMCID: 10414351

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.